Drug comparisons
Insulin Glulisine Human vs Donislecel
Insulin glulisine (Apidra) vs donislecel (Lantidra): rapid insulin analog compared to pancreatic islet cell therapy for type 1 diabetes.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 1 diabetes patients with recurrent severe hypoglycemia despite intensive regimens using rapid-acting insulins.
Bottom line
Insulin glulisine suits broad daily glycemic control while donislecel targets a narrow subset of type 1 patients with hypoglycemia unawareness.
All medication comparisons